Viela Bio collaborates with Hansoh Pharma to develop and commercialize inebilizumab for autoimmune diseases and hematologic cancers in China

Image: Viela Bio has collaborated with Hansoh Pharma to develop inebilizumab for autoimmune diseases and hematologic cancers in China. Photo: courtesy of Andrzej Pobiedziński / FreeImages.